|
1
|
Falk E, Nakano M, Bentzon JF, Finn AV and
Virmani R: Update on acute coronary syndromes: The pathologists'
view. Eur Heart J. 34:719–728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beaudeux JL, Giral P, Bruckert E,
Foglietti MJ and Chapman MJ: Matrix metalloproteinases,
inflammation and atherosclerosis: Therapeutic perspectives. Clin
Chem Lab Med. 42:121–131. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ketelhuth DF and Bäck M: The role of
matrix metalloproteinases in atherothrombosis. Curr Atheroscler
Rep. 13:162–169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Plutzky J: Atherosclerotic plaque rupture:
Emerging insights and opportunities. Am J Cardiol. 84:J15–J20.
1999. View Article : Google Scholar
|
|
5
|
Mason DP, Kenagy RD, Hasenstab D,
Bowen-Pope DF, Seifert RA, Coats S, Hawkins SM and Clowes AW:
Matrix metalloproteinase-9 overexpression enhances vascular smooth
muscle cell migration and alters remodeling in the injured rat
carotid artery. Circ Res. 85:1179–1185. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Newby AC: Dual role of matrix
metalloproteinases (matrixins) in intimal thickening and
atherosclerotic plaque rupture. Physiol Rev. 85:1–31. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ha KT, Lee TK, Kwak KH, Kim JK, Kim DI,
Choi DY and Kim CH: Inhibitory effect of Cho-Deung-San on human
aortic smooth muscle cell migration induced by TNF-alpha through
inhibition of matrix metalloproteinase-2 and −9 activity. Vasc
Pharmacol. 41:83–90. 2004. View Article : Google Scholar
|
|
8
|
Johnson JL, van Eys GJ, Angelini GD and
George SJ: Injury induces dedifferentiation of smooth muscle cells
and increased matrix-degrading metalloproteinase activity in human
saphenous vein. Arterioscler Thromb Vasc Biol. 21:1146–1151. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mattu HS and Randeva HS: Role of
adipokines in cardiovascular disease. J Endocrinol. 216:T17–T36.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li R, Chen LZ, Zhao SP and Huang XS:
Inflammation activation contributes to adipokine imbalance in
patients with acute coronary syndrome. PloS One. 11:e01519162016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Couillard C, Lamarche B, Mauriège P,
Cantin B, Dagenais GR, Moorjani S, Lupien PJ and Després JP:
Leptinemia is not a risk factor for ischemic heart disease in men.
Prospective results from the Quebec Cardiovascular Study. Diabetes
Care. 21:782–786. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Piemonti L, Calori G, Mercalli A, Lattuada
G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L and
Perseghin G: Fasting plasma leptin, tumor necrosis factor-alpha
receptor 2, and monocyte chemoattracting protein 1 concentration in
a population of glucose-tolerant and glucose-intolerant women:
Impact on cardiovascular mortality. Diabetes Care. 26:2883–2889.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Butler KR, Buxbaum SG, Sung JH,
Campbell BW and Taylor HA: Leptinemia and its association with
stroke and coronary heart disease in the Jackson Heart Study. Clin
Endocrinol (Oxf). 72:32–37. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tahergorabi Z and Khazaei M: Leptin and
its cardiovascular effects: Focus on angiogenesis. Adv Biomed Res.
4:792015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schneiderman J, Schaefer K, Kolodgie FD,
Savion N, Kotev-Emeth S, Dardik R, Simon AJ, Halak M, Pariente C,
Engelberg I, et al: Leptin locally synthesized in carotid
atherosclerotic plaques could be associated with lesion instability
and cerebral emboli. J Am Heart Assoc. 1:e0017272012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tao M, Yu P, Nguyen BT, Mizrahi B, Savion
N, Kolodgie FD, Virmani R, Hao S, Ozaki CK and Schneiderman J:
Schneiderman, locally applied leptin induces regional aortic wall
degeneration preceding aneurysm formation in apolipoprotein
E-deficient mice. Arterioscler Thromb Vasc Biol. 33:311–320. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schroeter MR, Eschholz N, Herzberg S,
Jerchel I, Leifheit-Nestler M, Czepluch FS, Chalikias G,
Konstantinides S and Schäfer K: Leptin-dependent and
leptin-independent paracrine effects of perivascular adipose tissue
on neointima formation. Arterioscler Thromb Vasc Biol. 33:980–987.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li H, Wang YP, Zhang LN and Tian G:
Perivascular adipose tissue-derived leptin promotes vascular smooth
muscle cell phenotypic switching via p38 mitogen-activated protein
kinase in metabolic syndrome rats. Exp Biol Med (Maywood).
239:954–965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schäfer K, Halle M, Goeschen C, Dellas C,
Pynn M, Loskutoff DJ and Konstantinides S: Leptin promotes vascular
remodeling and neointimal growth in mice. Arterioscler Thromb Vasc
Biol. 24:112–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oda A, Taniguchi T and Yokoyama M: Leptin
stimulates rat aortic smooth muscle cell proliferation and
migration. Kobe J Med Sci. 47:141–150. 2001.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pelleymounter MA, Cullen MJ, Baker MB,
Hecht R, Winters D, Boone T and Collins F: Effects of the obese
gene product on body weight regulation in ob/ob mice. Science.
269:540–543. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ross R: Rous-Whipple award lecture.
Atherosclerosis: A defense mechanism gone awry. Am J Pathol.
143:987–1002. 1993.PubMed/NCBI
|
|
24
|
Galis ZS, Sukhova GK, Lark MW and Libby P:
Increased expression of matrix metalloproteinases and matrix
degrading activity in vulnerable regions of human atherosclerotic
plaques. J Clin Invest. 94:2493–2503. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kampoli AM, Tousoulis D, Papageorgiou N,
Antoniades C, Androulakis E, Tsiamis E, Latsios G and Stefanadis C:
Matrix metalloproteinases in acute coronary syndromes: Current
perspectives. Curr Top Med Chem. 12:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kosztáczky B, Fóris G, Paragh G Jr, Seres
I, Zsiros E, Koncsos P, Balogh Z and Paragh G: Leptin stimulates
endogenous cholesterol synthesis in human monocytes: New role of an
old player in atherosclerotic plaque formation. Leptin-induced
increase in cholesterol synthesis. Int J Biochem Cell Biol.
39:1637–1645. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee K, Santibanez-Koref M, Polvikoski T,
Birchall D, Mendelow AD and Keavney B: Increased expression of
fatty acid binding protein 4 and leptin in resident macrophages
characterises atherosclerotic plaque rupture. Atherosclerosis.
226:74–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY,
Park BE, Jang Y, Cho SY and Kim HS: Potential role of leptin in
angiogenesis: Leptin induces endothelial cell proliferation and
expression of matrix metalloproteinases in vivo and in vitro. Exp
Mol Med. 33:95–102. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moon SK, Kim HM and Kim CH: PTEN induces
G1 cell cycle arrest and inhibits MMP-9 expression via the
regulation of NF-kappaB and AP-1 in vascular smooth muscle cells.
Arch Biochem Biophys. 421:267–276. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schneiderman J, Simon AJ, Schroeter MR,
Flugelman MY, Konstantinides S and Schaefer K: Leptin receptor is
elevated in carotid plaques from neurologically symptomatic
patients and positively correlated with augmented macrophage
density. J Vasc Surg. 48:1146–1155. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kang SM, Kwon HM, Hong BK, Kim D, Kim IJ,
Choi EY, Jang Y, Kim HS, Kim MS and Kwon HC: Expression of leptin
receptor (Ob-R) in human atherosclerotic lesions: Potential role in
intimal neovascularization. Yonsei Med J. 41:68–75. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Taleb S, Herbin O, Ait-Oufella H, Taleb S,
Herbin O, Ait-Oufella H, Verreth W, Gourdy P, Barateau V, Merval R,
et al: Defective leptin/leptin receptor signaling improves
regulatory T cell immune response and protects mice from
atherosclerosis. Arterioscler Thromb Vasc Biol. 27:2691–2698. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo W, Bodary PF, Shen Y, Wickenheiser KJ,
Ohman MK, Guo C, Bahrou KL, Myers MG Jr and Eitzman DT: Leptin
receptor-induced STAT3-independent signaling pathways are
protective against atherosclerosis in a murine model of obesity and
hyperlipidemia. Atherosclerosis. 214:81–85. 2011. View Article : Google Scholar : PubMed/NCBI
|
